 Below is an important message from one of our highly valued sponsors. Please read it carefully as they have some special information to share with you.
Dear Reader,
As co-host of The Clay Travis & Buck Sexton Show… one of the most listened-to radio programs in the country… I’ve conducted a lot of important interviews over the years…
But I’ve never done anything like this.
Take a look.
As you’re about to hear… there’s a rapidly developing and massively critical situation quickly unfolding in the Trump Administration right now…
The mainstream media – and very few Americans know anything about this.
But what I believe Trump has up his sleeve could flood an estimated $2.2 trillion into a handful of little-known technology companies over the next decade…
And potentially spark a 40-year economic boom that reshapes this country from the ground up.
I believe this will make history.
I wouldn’t be doing my job if I didn’t come forward and explain what’s happening.
This may be the most important message I’ve ever shared.
Please take a moment to watch my interview now.
You’ll be so glad you did.
Buck Sexton
Former CIA Officer and Co-Host, The Clay & Buck Show
Just For You The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock ValuationsWritten by Jeffrey Neal Johnson. Posted: 12/30/2025. 
Key Points- The removal of punitive federal tax codes would allow cannabis operators to deduct standard business expenses and finally generate sustainable free cash flow.
- Canopy Growth has successfully transitioned to an asset-light business model while securing strategic assets to trigger immediate entry into the American market.
- Tilray Brands leverages a robust craft beverage division to ensure financial stability and growth while maintaining a global footprint in the medical cannabis sector.
As the 2025 trading year draws to a close, the cannabis sector presents a confusing picture for many investors. On Dec. 18, 2025, President Trump signed a pivotal Executive Order directing the Attorney General to expedite the rescheduling of cannabis. By conventional measures, that political win should have sparked a sustained rally. Instead, the market staged a sharp sell-the-news correction. A tiny government task force just wrapped up 20 years of work.
And buried in their federal filings, I found something remarkable:
American citizens now have a legal birthright claim to something previously inaccessible.
Under U.S. law, you can stake your claim right now. The name and ticker are available here now >>> Leading equities in the space have fallen significantly and are trading near yearly lows, a sign of market exhaustion. Investors—tired after years of bureaucratic delays and false starts—largely focused on the lack of immediate, overnight legalization and ignored the order's longer-term implications. Experienced analysts, however, see a contrarian opportunity. The market is pricing cannabis stocks as if regulatory reform has already failed, even though data and political signals point toward a concrete change in 2026. That disconnect between depressed valuations and improving political probabilities has created an oversold condition. While the crowd is selling, the fundamental setup for 2026 suggests the sector may be coiled for a reversal. The Macro Catalyst: From Red Tape to Green CashThe turnaround case for 2026 centers on tax law. The Wildcard scenario depends on the administration successfully moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Though it may sound like an administrative tweak, that change would operate like a large corporate tax cut. Today, U.S. cannabis operators—and companies preparing to enter the market—are constrained by IRS Section 280E. That provision prevents businesses that traffic in Schedule I or II substances from deducting ordinary business expenses. - The Current Problem: A typical business deducts rent, payroll, and utilities from revenue before calculating taxes. Cannabis companies cannot; they are taxed on gross profit, which often produces effective tax rates of 70% or more and destroys cash flow.
- The 2026 Solution: If cannabis moves to Schedule III, Section 280E would no longer apply. Companies could immediately deduct standard operating costs.
For the stock market, this is the key variable. Removing 280E would transform the industry's financial model, allowing many companies to shift from burning cash to generating free cash flow. If the Executive Order signed in December results in a finalized rule in 2026, valuations would likely reset to reflect that profitable reality. Canopy Growth Corporation: The Aggressive U.S. BetFor investors seeking aggressive exposure to a potential opening of the U.S. market, Canopy Growth Corporation (NASDAQ: CGC) remains a primary vehicle. The company has spent the past two years reshaping its business into an asset-light model, divesting large cultivation facilities to reduce overhead and preserve capital. Canopy's thesis centers on Canopy USA—a structure that lets the company hold economic interests in U.S. assets without violating NASDAQ listing rules. The idea is binary: once federal rescheduling permits, Canopy USA could complete acquisitions of those U.S. assets and immediately consolidate their revenue. Meanwhile, Canopy is taking concrete steps to strengthen its position. On Dec. 15, 2025, the company announced the strategic acquisition of MTL Cannabis. - Supply Chain Security: The deal secures a consistent, high-quality flower supply—vital for protecting market share in Canada.
- Export Capability: MTL bolsters Canopy's ability to serve international medical markets, providing revenue while the U.S. strategy develops.
Combined with a cost-reduction program delivering roughly $21 million in annualized savings, Canopy has positioned itself to survive current volatility and scale quickly if the regulatory environment shifts. Tilray Brands: The Diversified FortressTilray Brands, Inc. (NASDAQ: TLRY) offers a different risk/reward: stability through diversification. Rather than tying the company's fate to a single regulatory outcome, Tilray operates on three pillars: cannabis, wellness, and beverage alcohol. If political delays persist into 2026, Tilray has a built-in safety net. After acquisitions in 2024, Tilray is now the fifth-largest craft brewer in the U.S., owning recognizable brands such as Hop Valley and Terrapin. Revenue from craft beer and spirits provides reliable cash flow that cushions the company from cannabis-sector volatility. The company is also executing Project 420, an effort to streamline operations and save millions across its beverage and cannabis lines. Management has further cleaned up the capital structure: on Dec. 1, 2025, Tilray executed a 1-for-10 reverse stock split. - Institutional Access: Many large funds cannot buy stocks trading under $5. By consolidating the share count, Tilray reopened access to institutional investors.
- Compliance: The move improves long-term compliance with NASDAQ and reduces delisting risk.
Tilray also maintains a strong European presence, holding a cultivation license under Germany's new Cannabis Act—giving it an international revenue stream independent of U.S. policy. The Bear Trap: Anatomy of a Short SqueezeBoth Canopy Growth and Tilray Brands are trading at historically low valuations relative to sales. Yet short interest—the volume of shares borrowed by investors betting the price will fall—remains elevated. Those short sellers are wagering that the federal government will fail to carry out the rescheduling order, creating a high-risk position for the bears. - The Trap: If a clear positive development arrives—such as the DEA publishing a final Schedule III rule—the rationale for shorting these stocks would collapse.
- The Scramble: Short sellers would need to buy shares to cover positions and exit their trades.
- The Squeeze: That forced buying can create a feedback loop: rising prices force more covering, which pushes prices higher still.
Given the overwhelmingly negative sentiment, even modest good news could trigger this chain reaction. The heavy short positioning is dry powder; a regulatory spark could ignite a rapid and violent upside move. 2026 Outlook: Time for ExecutionWhile 2025 was defined by waiting, the landscape for 2026 looks different. Companies are leaner, cost structures have improved, and the President has issued a direct order to reduce regulatory barriers. Investors now face a binary window. If the administration follows through, removing the 280E tax burden could justify substantially higher stock prices. The sector is moving from hope to execution. For those watching closely, current prices carry risk—but they may also represent a historic discount if the political wildcard plays out in the industry's favor.
This ad is sent on behalf of Paradigm Press, LLC, at 1001 Cathedral St., Baltimore, MD 21201. If you're not interested in this opportunity from Paradigm Press, LLC, please click here to remove your email from these offers. | 
0 التعليقات:
إرسال تعليق